Fenoprofen, 600 mg, three times daily, was compared with phenylbutazone, 100 mg, three times daily, in 30 patients suffering from ankylosing spondylitis in a double-blind cross-over study. Assessments were made after an initial washout period and after each month-long treatment period. Phenylbutazone significantly improved morning stiffness, finger-to-floor distance, chest expansion, overall joint pain, spinal pain, the physician's assessment of disease activity and ESR. Only chest expansion ...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
A double-blind cross-over trial of fenoprofen and phenylbutazone in ankylosing spondylitis.
If you are the owner of this record, you can report an update to it here: Report update to this record